Clinical Trial Update: Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 1/2 study evaluating paclitaxel with radiation therapy plus the chemoprotectant amifostine in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Amifostine (amifostine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Head and Neck Cancer, Oral Complications | Phase 1, Phase 2 | Status: COMPLETED